BACKGROUND: Inadequate hepcidin production leads to iron overload in nearly all types of hemochromatosis. We explored the acute response of hepcidin to iron challenge in 25 patients with HFE-hemochromatosis, in two with TFR2-hemochromatosis and in 13 controls. Sixteen patients (10 C282Y/C282Y homozygotes, 6 C282Y/H63D compound heterozygotes) had increased iron stores, while nine (6 C282Y/C282Y homozygotes, 3 C282Y/H63D compound heterozygotes) were studied after phlebotomy-induced normalization of iron stores. DESIGN AND METHODS: We analyzed serum iron, transferrin saturation, and serum hepcidin by both enzyme-linked immunosorbent assay and mass-spectrometry at baseline, and 4, 8, 12 and 24 hours after a single 65-mg dose of oral iron. RESULTS: Serum iron and transferrin saturation significantly increased at 4 hours and returned to baseline values at 8-12 hours in all groups, except in the iron-normalized patients who showed the highest and longest increase of both parameters. The level of hepcidin increased significantly at 4 hours and returned to baseline at 24 hours in controls and in the C282Y/H63D compound heterozygotes at diagnosis. The hepcidin response was smaller in C282Y-homozygotes than in controls, barely detectable in the patients with iron-depleted HFE-hemochromatosis and absent in those with TFR2-hemochromatosis. Conclusions Our results are consistent with a scenario in which TFR2 plays a prominent and HFE a contributory role in the hepcidin response to a dose of oral iron. In iron-normalized patients with HFE hemochromatosis, both the low baseline hepcidin level and the weak response to iron contribute to hyperabsorption of iron.
BACKGROUND: Inadequate hepcidin production leads to iron overload in nearly all types of hemochromatosis. We explored the acute response of hepcidin to iron challenge in 25 patients with HFE-hemochromatosis, in two with TFR2-hemochromatosis and in 13 controls. Sixteen patients (10 C282Y/C282Y homozygotes, 6 C282Y/H63D compound heterozygotes) had increased iron stores, while nine (6 C282Y/C282Y homozygotes, 3 C282Y/H63D compound heterozygotes) were studied after phlebotomy-induced normalization of iron stores. DESIGN AND METHODS: We analyzed serum iron, transferrin saturation, and serum hepcidin by both enzyme-linked immunosorbent assay and mass-spectrometry at baseline, and 4, 8, 12 and 24 hours after a single 65-mg dose of oral iron. RESULTS: Serum iron and transferrin saturation significantly increased at 4 hours and returned to baseline values at 8-12 hours in all groups, except in the iron-normalized patients who showed the highest and longest increase of both parameters. The level of hepcidin increased significantly at 4 hours and returned to baseline at 24 hours in controls and in the C282Y/H63D compound heterozygotes at diagnosis. The hepcidin response was smaller in C282Y-homozygotes than in controls, barely detectable in the patients with iron-depleted HFE-hemochromatosis and absent in those with TFR2-hemochromatosis. Conclusions Our results are consistent with a scenario in which TFR2 plays a prominent and HFE a contributory role in the hepcidin response to a dose of oral iron. In iron-normalized patients with HFE hemochromatosis, both the low baseline hepcidin level and the weak response to iron contribute to hyperabsorption of iron.
Authors: Joyce J C Kroot; Jan C M Hendriks; Coby M M Laarakkers; Siem M Klaver; Erwin H J M Kemna; Harold Tjalsma; Dorine W Swinkels Journal: Anal Biochem Date: 2009-03-31 Impact factor: 3.365
Authors: Joyce J C Kroot; Erwin H J M Kemna; Sukhvinder S Bansal; Mark Busbridge; Natascia Campostrini; Domenico Girelli; Robert C Hider; Vasiliki Koliaraki; Avgi Mamalaki; Gordana Olbina; Naohisa Tomosugi; Chris Tselepis; Douglas G Ward; Tomas Ganz; Jan C M Hendriks; Dorine W Swinkels Journal: Haematologica Date: 2009-12 Impact factor: 9.941
Authors: Hiroshi Kawabata; Robert E Fleming; Dorina Gui; Seo Y Moon; Takayuki Saitoh; James O'Kelly; Yutaka Umehara; Yuji Wano; Jonathan W Said; H Phillip Koeffler Journal: Blood Date: 2004-09-02 Impact factor: 22.113
Authors: George Papanikolaou; Mark E Samuels; Erwin H Ludwig; Marcia L E MacDonald; Patrick L Franchini; Marie-Pierre Dubé; Lisa Andres; Julie MacFarlane; Nikos Sakellaropoulos; Marianna Politou; Elizabeta Nemeth; Jay Thompson; Jenni K Risler; Catherine Zaborowska; Ryan Babakaiff; Christopher C Radomski; Terry D Pape; Owen Davidas; John Christakis; Pierre Brissot; Gillian Lockitch; Tomas Ganz; Michael R Hayden; Y Paul Goldberg Journal: Nat Genet Date: 2003-11-30 Impact factor: 38.330
Authors: Dorine W Swinkels; Domenico Girelli; Coby Laarakkers; Joyce Kroot; Natascia Campostrini; Erwin H J M Kemna; Harold Tjalsma Journal: PLoS One Date: 2008-07-16 Impact factor: 3.240
Authors: Walter Bialkowski; Joseph E Kiss; David J Wright; Ritchard Cable; Rebecca Birch; Pam D'Andrea; Barbara J Bryant; Bryan R Spencer; Alan E Mast Journal: Am J Hematol Date: 2017-06-09 Impact factor: 10.047
Authors: Patrick Gutschow; Huiling Han; Gordana Olbina; Keith Westerman; Elizabeta Nemeth; Tomas Ganz; Karen Copeland; Mark Westerman; Vaughn Ostland Journal: J Appl Lab Med Date: 2020-09-01